Christy J. Oliger - 08 Jun 2022 Form 4 Insider Report for REATA PHARMACEUTICALS INC

Role: Director
Signature: /s/ Tracy Herson, attorney-in-fact
Issuer symbol: N/A
Transactions as of: 08 Jun 2022
Net transactions value: +$134,973
Form type: 4
Filing time: 09 Jun 2022, 16:42:33 UTC
Previous filing: 20 May 2022
Next filing: 01 Jul 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RETA	Class A common stock	Award	$134,973	+3,883		$34.76	3,883	08 Jun 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RETA	Stock Option (right-to-buy)	Award	$0	+5,620		$0.000000	5,620	08 Jun 2022	Class A common stock	5,620	$34.76	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares represent Restricted Stock Units (RSU), which vest in four equal installments on September 14, 2022, December 8, 2022, March 1, 2023, and June 7, 2023, subject to continued service through the vesting date.
F2	The options vest in four equal installments on September 14, 2022, December 8, 2022, March 1, 2023, and June 7, 2023, subject to continued service through the vesting date.